Cardiovascular Disease on the Rise in the U.S.

Share this article:
Rate of Cardiovascular Disease Expected to Rise in the U.S.
Rate of Cardiovascular Disease Expected to Rise in the U.S.

The combined effects of aging of the population and the obesity epidemic are expected to increase the prevalence of cardiovascular disease in the United States, according to research published in Health Affairs.

Ankur Pandya, Ph.D., of the Weill Cornell Medical College in New York City, and colleagues used data for 1973 to 2010 from National Health and Nutrition Examination Surveys to predict risk and prevalence of cardiovascular disease for 2015 to 2030.

The researchers found that the effects of decreasing smoking rates and improved treatments on the prevalence of cardiovascular disease will be countered by aging of the population and obesity. An increase in the prevalence of cardiovascular disease is anticipated, with associated increases in health care costs, disability, and reduced quality of life.

"Our analyses show the importance of curbing obesity and improving cholesterol and blood pressure treatment to reduce projected risk and prevalence of cardiovascular disease," the authors write.

This article originally appeared here.
Share this article:
You must be a registered member of RUN to post a comment.
close

Next Article in Cardiovascular Disease (CVD)

More in Cardiovascular Disease (CVD)

USPSTF: Counseling Recommended for Cardiovascular Risk

USPSTF: Counseling Recommended for Cardiovascular Risk

Overweight or obese adults with risk factors should be referred for intensive behavioral counseling.

Troponin Has Prognostic Value in Chronic Kidney Disease

Troponin Has Prognostic Value in Chronic Kidney Disease

Second review shows value in CKD with suspected ACS, limited by variable sensitivity/specificity.

Allopurinol Offers No Cardiovascular Benefit

Allopurinol Offers No Cardiovascular Benefit

Allopurinol therapy is not associated with beneficial cardiovascular outcomes in gout patients.